Growth Metrics

Rigel Pharmaceuticals (RIGL) Share-based Compensation Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 206.26%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -69.95%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.18%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.66%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 23.70%
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn 3.97%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.97%
Dec 31, 2025 31.67%
Sep 30, 2025 27.19%
Jun 30, 2025 29.59%
Mar 31, 2025 -35.26%
Dec 31, 2024 7.97%
Sep 30, 2024 36.08%
Jun 30, 2024 16.39%
Mar 31, 2024 86.15%
Dec 31, 2023 -52.62%
Sep 30, 2023 -28.22%
Jun 30, 2023 -9.16%
Mar 31, 2023 -14.00%
Dec 31, 2022 74.43%
Sep 30, 2022 22.93%
Jun 30, 2022 3.69%
Mar 31, 2022 21.52%
Dec 31, 2021 43.50%
Sep 30, 2021 16.88%
Jun 30, 2021 31.25%
Mar 31, 2021 30.39%
Dec 31, 2020 15.52%
Sep 30, 2020 -10.20%
Jun 30, 2020 -33.77%
Mar 31, 2020 -31.46%
Dec 31, 2019 -31.40%
Sep 30, 2019 -29.95%
Jun 30, 2019 138.58%
Mar 31, 2019 91.75%
Dec 31, 2018 -32.76%
Sep 30, 2018 243.07%
Jun 30, 2018 1.09%
Mar 31, 2018 61.26%
Dec 31, 2017 178.09%
Sep 30, 2017 -49.07%
Jun 30, 2017 -45.38%
Mar 31, 2017 -33.59%
Dec 31, 2016 -32.31%
Sep 30, 2016 -5.56%
Jun 30, 2016 5.50%
Mar 31, 2016 -29.99%
Dec 31, 2015 8.33%
Sep 30, 2015 -12.74%
Jun 30, 2015 -10.46%
Mar 31, 2015 -13.11%
Dec 31, 2014 -4.03%
Sep 30, 2014 770.29%
Jun 30, 2014 22.04%
Mar 31, 2014 31.85%
Dec 31, 2013 -52.10%
Sep 30, 2013 -92.63%
Jun 30, 2013 -41.98%
Mar 31, 2013 -42.12%
Dec 31, 2012 7.30%
Sep 30, 2012 5.02%
Jun 30, 2012 -5.91%
Mar 31, 2012 -19.26%
Dec 31, 2011 -19.99%
Sep 30, 2011 -17.97%